1
|
Lau EMT, Giannoulatou E, Celermajer DS and
Humbert M: Epidemiology and treatment of pulmonary arterial
hypertension. Nat Rev Cardiol. 14:603–614. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen KH, Dasgupta A, Lin J, Potus F,
Bonnet S, Iremonger J, Fu J, Mewburn J, Wu D, Dunham-Snary K, et
al: Epigenetic dysregulation of the Drp1 binding partners MiD49 and
MiD51 increases mitotic mitochondrial fission and promotes
pulmonary arterial hypertension: Mechanistic and therapeutic
implications. Circulation. 138:287–304. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Maron BA and Leopold JA: Emerging concepts
in the molecular basis of pulmonary arterial hypertension: Part II:
Neurohormonal signaling contributes to the pulmonary vascular and
right ventricular pathophenotype of pulmonary arterial
hypertension. Circulation. 131:2079–2091. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ten Freyhaus H, Berghausen EM, Janssen W,
Leuchs M, Zierden M, Murmann K, Klinke A, Vantler M, Caglayan E,
Kramer T, et al: Genetic ablation of PDGF-Dependent signaling
pathways abolishes vascular remodeling and experimental pulmonary
hypertension. Arterioscler Thromb Vasc Biol. 35:1236–1245. 2015.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Tallquist M and Kazlauskas A: PDGF
signaling in cells and mice. Cytokine Growth Factor Rev.
15:205–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sysol JR, Natarajan V and Machado RF: PDGF
induces SphK1 expression via Egr-1 to promote pulmonary artery
smooth muscle cell proliferation. Am J Physiol Cell Physiol.
310:C983–C992. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chen J, Cui X, Li L, Qu J, Raj JU and Gou
D: MiR-339 inhibits proliferation of pulmonary artery smooth muscle
cell by targeting FGF signaling. Physiol Rep. 5:e134412017.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Picao-Osorio J, Johnston J, Landgraf M,
Berni J and Alonso CR: MicroRNA-encoded behavior in drosophila.
Science. 350:815–820. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Xiao T, Xie L, Huang M and Shen J:
Differential expression of microRNA in the lungs of rats with
pulmonary arterial hypertension. Mol Med Rep. 15:591–596. 2017.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Thenappan T, Ormiston ML, Ryan JJ and
Archer SL: Pulmonary arterial hypertension: Pathogenesis and
clinical management. BMJ. 360:j54922018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Courboulin A, Paulin R, Giguère NJ,
Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher
S, Côté J, et al: Role for miR-204 in human pulmonary arterial
hypertension. J Exp Med. 208:535–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Sahoo S, Meijles DN, Al Ghouleh I, Tandon
M, Cifuentes-Pagano E, Sembrat J, Rojas M, Goncharova E and Pagano
PJ: MEF2C-MYOCD and Leiomodin1 suppression by miRNA-214 promotes
smooth muscle cell phenotype switching in pulmonary arterial
hypertension. PLoS One. 11:e01537802016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang WF, Xiong YW, Zhu TT, Xiong AZ, Bao
HH and Cheng XS: MicroRNA let-7g inhibited hypoxia-induced
proliferation of PASMCs via G0/G1 cell cycle arrest by targeting
c-myc. Life Sci. 170:9–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Deng L, Baker AH and Bradshaw AC: MicroRNA
delivery strategies to the lung in a model of pulmonary
hypertension. Methods Mol Biol. 1521:325–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Bertero T, Cottrill K, Krauszman A, Lu Y,
Annis S, Hale A, Bhat B, Waxman AB, Chau BN, Kuebler WM and Chan
SY: The microRNA-130/301 family controls vasoconstriction in
pulmonary hypertension. J Biol Chem. 290:2069–2085. 2015.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Liu HM, Jia Y, Zhang YX, Yan J, Liao N, Li
XH and Tang Y: Dysregulation of miR-135a-5p promotes the
development of rat pulmonary arterial hypertension in vivo and in
vitro. Acta Pharmacol Sin. 2018.
|
17
|
Choe N, Kwon JS, Kim JR, Eom GH, Kim Y,
Nam KI, Ahn Y, Kee HJ and Kook H: The microRNA miR-132 targets
Lrrfip1 to block vascular smooth muscle cell proliferation and
neointimal hyperplasia. Atherosclerosis. 229:348–355. 2013.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Jin W, Reddy MA, Chen Z, Putta S, Lanting
L, Kato M, Park JT, Chandra M, Wang C, Tangirala RK and Natarajan
R: Small RNA sequencing reveals microRNAs that modulate angiotensin
II effects in vascular smooth muscle cells. J Biol Chem.
287:15672–15683. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lai YJ, Hsu HH, Chang GJ, Lin SH, Chen WJ,
Huang CC and Pang JS: Prostaglandin E1 attenuates pulmonary artery
remodeling by activating phosphorylation of CREB and the PTEN
signaling pathway. Sci Rep. 7:99742017. View Article : Google Scholar : PubMed/NCBI
|
20
|
National Research Council, . Guide for the
care and use of laboratory animals. 8th. Washington (DC): National
Academies Press (US); 2011, PubMed/NCBI
|
21
|
Wu WH, Hu CP, Chen XP, Zhang WF, Li XW,
Xiong XM and Li YJ: MicroRNA-130a mediates proliferation of
vascular smooth muscle cells in hypertension. Am J Hypertens.
24:1087–1093. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zeng Z, Huang Q, Shu Z, Liu P, Chen S, Pan
X, Zang L and Zhou S: Effects of short-chain acyl-CoA dehydrogenase
on cardiomyocyte apoptosis. J Cell Mol Med. 20:1381–1391. 2016.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Bienertova-Vasku J, Novak J and Vasku A:
MicroRNAs in pulmonary arterial hypertension: Pathogenesis,
diagnosis and treatment. J Am Soc Hypertens. 9:221–234. 2015.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Leopold JA and Maron BA: Molecular
mechanisms of pulmonary vascular remodeling in pulmonary arterial
hypertension. Int J Mol Sci. 17:E7612016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Ucar A, Gupta SK, Fiedler J, Erikci E,
Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann
A, et al: The miRNA-212/132 family regulates both cardiac
hypertrophy and cardiomyocyte autophagy. Nat Commun. 3:10782012.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Eskildsen TV, Jeppesen PL, Schneider M,
Nossent AY, Sandberg MB, Hansen PB, Jensen CH, Hansen ML, Marcussen
N, Rasmussen LM, et al: Angiotensin II regulates microRNA-132/-212
in hypertensive rats and humans. Int J Mol Sci. 14:11190–11207.
2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Anand S, Majeti BK, Acevedo LM, Murphy EA,
Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN,
Lapinski PE, et al: MicroRNA-132-mediated loss of p120RasGAP
activates the endothelium to facilitate pathological angiogenesis.
Nat Med. 16:909–914. 2010. View
Article : Google Scholar : PubMed/NCBI
|
29
|
Ghataorhe P, Rhodes CJ, Harbaum L, Attard
M, Wharton J and Wilkins MR: Pulmonary arterial
hypertension-progress in understanding the disease and prioritizing
strategies for drug development. J Intern Med. 282:129–141. 2017.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Lythgoe MP, Rhodes CJ, Ghataorhe P, Attard
M, Wharton J and Wilkins MR: Why drugs fail in clinical trials in
pulmonary arterial hypertension, and strategies to succeed in the
future. Pharmacol Ther. 164:195–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yoshida T and Hayashi M: Role of
kruppel-like factor 4 and its binding proteins in vascular disease.
J Atheroscler Thromb. 21:402–413. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Alexander MR and Owens GK: Epigenetic
control of smooth muscle cell differentiation and phenotypic
switching in vascular development and disease. Annu Rev Physiol.
74:13–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Liu Y, Sinha S, McDonald OG, Shang Y,
Hoofnagle MH and Owens GK: Kruppel-like factor 4 abrogates
myocardin-induced activation of smooth muscle gene expression. J
Biol Chem. 280:9719–9727. 2005. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ravi Y, Selvendiran K, Meduru S, Citro L,
Naidu S, Khan M, Rivera BK, Sai-Sudhakar CB and Kuppusamy P:
Dysregulation of PTEN in cardiopulmonary vascular remodeling
induced by pulmonary hypertension. Cell Biochem Biophys.
67:363–372. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Lee YR, Chen M and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor: New modes
and prospects. Nat Rev Mol Cell Biol. 19:547–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
36
|
Liu Y, Cao Y, Sun S, Zhu J, Gao S, Pang J,
Zhu D and Sun Z: Transforming growth factor-beta1 upregulation
triggers pulmonary artery smooth muscle cell proliferation and
apoptosis imbalance in rats with hypoxic pulmonary hypertension via
the PTEN/AKT pathways. Int J Biochem Cell Biol. 77:141–154. 2016.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Zhu B, Gong Y, Yan G, Wang D, Qiao Y, Wang
Q, Liu B, Hou J, Li R and Tang C: Down-regulation of lncRNA MEG3
promotes hypoxia-induced human pulmonary artery smooth muscle cell
proliferation and migration via repressing PTEN by sponging miR-21.
Biochem Biophys Res Commun. 495:2125–2132. 2018. View Article : Google Scholar : PubMed/NCBI
|